Cargando…
Dual-Use Vaccine for Diarrhoeal Diseases: Cross-Protective Immunogenicity of a Cold-Chain-Free, Live-Attenuated, Oral Cholera Vaccine against Enterotoxigenic Escherichia coli (ETEC) Challenge in BALB/c Mice
In low- and middle-income countries, diarrhoeal diseases are the second most common cause of mortality in children, mainly caused by enterotoxin-producing bacteria, such as Shigella, Vibrio, Salmonella, and Escherichia coli. Cholera and traveller’s diarrhoea are caused by Vibrio cholerae (O1 and O13...
Autores principales: | Hui Xian, Tew, Parasuraman, Subramani, Ravichandran, Manickam, Prabhakaran, Guruswamy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787504/ https://www.ncbi.nlm.nih.gov/pubmed/36560571 http://dx.doi.org/10.3390/vaccines10122161 |
Ejemplares similares
-
Live, Genetically Attenuated, Cold-Chain-Free Cholera Vaccine—A Research and Development Journey: Light at the End of a Long Tunnel
por: RAVICHANDRAN, Manickam, et al.
Publicado: (2022) -
From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development
por: Svennerholm, Ann-Mari
Publicado: (2011) -
Immunogenicity and protective efficacy of a live, oral cholera vaccine formulation stored outside-the-cold-chain for 140 days
por: Xian, Tew Hui, et al.
Publicado: (2020) -
Immunogenicity and protective efficacy of enterotoxigenic Escherichia coli (ETEC) total RNA against ETEC challenge in a mouse model
por: Liu, Mandi, et al.
Publicado: (2020) -
Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge
por: Harro, Clayton, et al.
Publicado: (2019)